Green Cross has ranked among the top searched stocks for 14 days over the past month.


As of 2:30 p.m. on November 18, Green Cross is trading at 388,500 KRW, down 0.64% from the previous day. This represents a 76.99% increase compared to October 21. Green Cross is known as a pharmaceutical company specializing in blood products and vaccines.

Today, foreign investors have made a net purchase of 8,786 shares of Green Cross, while institutional investors have made a net sale of 1,000 shares, according to provisional data. Over the past five days, individual investors have made a net sale of 124,950 shares, while foreign investors and institutional investors have made net purchases of 147,459 shares and net sales of 30,389 shares, respectively.


On November 11, Green Cross became a market topic as it was identified as the "point at which new vaccine CMO value is reflected."





[Table] Net Purchases and Sales by Foreign and Institutional Investors (Unit: shares)

※ Source: AI investment assistant AI Rassiro


※ This article was automatically generated in real time by a news algorithm jointly developed by Asia Economy and Thinkpool, a financial AI specialist company.



This content was produced with the assistance of AI translation services.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Today’s Briefing